Biography and Research Information
OverviewAI-generated summary
CD O'Brien's research focuses on understanding and treating bone health issues, particularly in the context of metastatic breast cancer. Recent work has investigated the potential of senolytics, a class of drugs targeting senescent cells, to improve bone health by depleting senescent osteocytes. This line of inquiry aims to identify therapeutic strategies that can mitigate skeletal complications associated with cancer progression and treatment. O'Brien has published seven papers to date, with a recent publication in 2024, and maintains an h-index of 2. Collaborations include work with Hayley M. Sabol, Japneet Kaur, Elena Ambrogini, and Maria Almeida, all affiliated with the University of Arkansas for Medical Sciences.
Metrics
- h-index: 2
- Publications: 7
- Citations: 10
Selected Publications
-
Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer (2024)
Collaboration Network
Top Collaborators
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
- Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer
Similar Researchers
Based on overlapping research topics